Larson Financial Group’s iRadimed IRMD Stock Holding History

Larson Financial Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.5K	Buy	411 +27	+7%	+$2.7K	﹤0.01%	1474
2025 Q4	$37.4K	Buy	384 +23	+6%	+$1.97K	﹤0.01%	1387
2025 Q3	$25.7K	Sell	361 -307	-46%	-$20.5K	﹤0.01%	1498
2025 Q2	$39.9K	Buy	668 +624	+1,418%	+$34.2K	﹤0.01%	1161
2025 Q1	$2.31K	Buy	44 +14	+47%	+$787	﹤0.01%	2121
2024 Q4	$1.65K	Buy	30 +15	+100%	+$789	﹤0.01%	1924
2024 Q3	$754	Buy	+15	New	+$692	﹤0.01%	2048

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Larson Financial Group's IRMD Position: Q1 2026 in Review

Larson Financial Group increased its iRadimed (IRMD) stake by 7% in Q1 2026, buying an estimated $2.7K and bringing the position to 411 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Larson Financial Group first reported a position in IRMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $39.9K in Q2 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Larson Financial Group held 411 shares of iRadimed worth $39.5K as of Q1 2026.
Larson Financial Group bought 27 iRadimed shares in Q1 2026, an estimated $2.7K.
iRadimed made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1474 holding.
Larson Financial Group first reported a position in iRadimed in Q3 2024 and has held it in 7 quarters since.
Larson Financial Group's iRadimed position peaked at $39.9K in Q2 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.